Skip to content

Use of Rajat Bhasma as Rasayana (Rejuvenating agent)

Comparative Pharmaceutico-Analytical Study of Rajat Bhasma and Its Clinical Evaluation as Rasayana

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/02/031080
Enrollment
20
Registered
2021-02-08
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Rajat bhasma-I: 125 mg once a day for 30 days Control Intervention1: Rajat bhasma-II: 125 mg once a day for 30 days

Sponsors

Principal Rajiv Gandhi Govt PG Ayurvedic College Paprola
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Apparently healthy individuals willing to undergo trial. 2) Individuals ready to give written consent. 3) Healthy volunteers of either sex aged between 18-60 years.

Exclusion criteria

Exclusion criteria: 1) Individuals not willing to undergo clinical trial 2) Individuals below 18 and above 60 years of age 3) Individuals suffering from any systemic diseases and congenital anomalies. 4) Any other condition which is considered unfit for inclusion in trial.

Design outcomes

Primary

MeasureTime frame
Fulfillment of objective [Haemoglobin, Body weight, BMI, Blood pressure ]and subjective criteria [General feeling of well being, Fatigue, Annabhilasha (Desire for food), BhuktasyaParipaka (Easy digestion of food), Suprasannendriyatwa (Perspicuity of Indriyas), Sukhaswapnaprabodanam (Comfortable sleep and awakening), BalaLabha (Attainment of strength), Soumanasya (happiness), Vulnerability to diseases, Kanti (Lusture of skin)] Timepoint: 30 days

Secondary

MeasureTime frame
General feeling of well beingTimepoint: 30 days

Countries

India

Contacts

Public ContactDr Diksha Sharma

Rajiv Gandhi Government PG Ayurvedic College

chanderpaul.kashyap@gmail.com7018010803

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026